| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2015/03/26 | 23 : 12 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2015/02/18 | 02 : 10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2014/02/21 | 07 : 00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/11/05 | 04 : 23 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/30 | 19 : 00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 08 : 51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 08 : 39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 07 : 09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 06 : 58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 06 : 42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 06 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 05 : 51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 04 : 53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 04 : 24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 04 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/29 | 03 : 21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/26 | 06 : 25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 03 : 29 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/25 | 01 : 55 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/24 | 22 : 47 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/24 | 05 : 32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 2013/10/15 | 22 : 23 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |